The Jenner Institute, the home of a University of Oxford human trial into a coronavirus vaccine, in Oxford, the UK, on July 20 2020. Picture: BLOOMBERG/DAVID LEVENSON
The experimental vaccine, which has been licensed to AstraZeneca, produced an immune response in early-stage clinical trials, data showed on Monday, preserving the hope it could be in use by the end of the year. She said it needed to be shown to work in late-stage trials, there needed to be large quantities manufactured and regulators had to agree quickly to license it for emergency use.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: